5-bromo-4-chloro-3-indoxyl-beta-d-xylopyranoside

Modify Date: 2025-08-26 11:57:14

5-bromo-4-chloro-3-indoxyl-beta-d-xylopyranoside Structure
5-bromo-4-chloro-3-indoxyl-beta-d-xylopyranoside structure
Common Name 5-bromo-4-chloro-3-indoxyl-beta-d-xylopyranoside
CAS Number 207606-55-1 Molecular Weight 378.60300
Density 1.907g/cm3 Boiling Point 620.6ºC at 760 mmHg
Molecular Formula C13H13BrClNO5 Melting Point N/A
MSDS USA Flash Point 329℃

 Names

Name (2S,3R,4S,5R)-2-[(5-bromo-4-chloro-1H-indol-3-yl)oxy]oxane-3,4,5-triol
Synonym More Synonyms

 Chemical & Physical Properties

Density 1.907g/cm3
Boiling Point 620.6ºC at 760 mmHg
Molecular Formula C13H13BrClNO5
Molecular Weight 378.60300
Flash Point 329℃
Exact Mass 376.96700
PSA 94.94000
LogP 1.40160
Vapour Pressure 2.92E-16mmHg at 25°C
Index of Refraction 1.746
Storage condition Freezer (-20°C)

 MSDS

Name: 5-Bromo-4-chloro-3-indoxyl--D-xylopyranoside Material Safety Data Sheet
Synonym:
CAS: 207606-55-1
Section 1 - Chemical Product MSDS Name:5-Bromo-4-chloro-3-indoxyl--D-xylopyranoside Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
207606-55-1 5-Bromo-4-chloro-3-indoxyl--D-xylopyr unlisted
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
May cause respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a tightly closed container. Deep freeze (below -20C).

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 207606-55-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: colorless to white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: practically insoluble
Specific Gravity/Density:
Molecular Formula: C13H13BrClNO5
Molecular Weight: 378.61

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, light.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide, hydrogen bromide.
Hazardous Polymerization: Will not occur.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 207606-55-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-Bromo-4-chloro-3-indoxyl--D-xylopyranoside - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 207606-55-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 207606-55-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 207606-55-1 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Personal Protective Equipment Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Safety Phrases S24/25
RIDADR NONH for all modes of transport
WGK Germany 3

 Synonyms

X-Xyl
MFCD00152013
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Related Compounds: More...
5-bromo-4-chloro-3-indoxyl-beta-d-mannopyranoside
129787-67-3
5-BROMO-4-CHLORO-3-INDOXYL-BETA-D-RIBOFURANOSIDE
518033-33-5
5-bromo-4-chloro-3-indoxyl-beta-d-fucopyranoside
17016-46-5
5-bromo-4-chloro-3-indoxyl-beta-l-fucopyranoside
125328-84-9
5-Bromo-4-chloro-3-indolyl-beta-D-glucuronide sodium salt
129541-41-9
5-Bromo-4-chloro-3-indolyl-beta-D-glucoside
15548-60-4
5-bromo-4-chloro-3-indolyl beta-d-cellobioside
177966-52-8
5-bromo-4-chloro-3-indolylglucuronide
18656-89-8
5-Bromo-4-chloro-3-indolyl-N-acetyl-beta-D-glucosaminide
4264-82-8
N-(2-Bromophenyl)-6-methylpyrazine-2-carboxamide
2415520-08-8
N-(4-Methoxyphenyl)piperidin-4-amine dihydrochloride
1951439-07-8
1-[2-[[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]acetyl]amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide
1797406-83-7
(3R)-3-{[(tert-butoxy)carbonyl]amino}-3-(4-iodophenyl)propanoic acid
1366273-76-8
Tetrabutylammonium (1R,2S,5R)-2-(2-((R)-1-(tert-butoxycarbonyl)piperidine-3-carbonyl)hydrazinecarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate
1436862-01-9
5-chloro-2-[(1R)-1-hydroxyethyl]-3-phenyl-3,4-dihydroquinazolin-4-one
2573124-08-8
(2E)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-2-enamide
1228646-19-2
(1R,5S,6R)-6-(4H-1,2,4-triazol-4-yl)-3-azabicyclo[3.1.0]hexane dihydrochloride
2415312-61-5
tert-Butyl (8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3,4,5-tetrahydrobenzo[b]oxepin-5-yl)carbamate
2412760-61-1
2-(2-Fluorophenyl)butan-1-amine hydrochloride
2490709-26-5